Viridian Therapeutics, Inc.\DE (VRDN) Weighted Average Number of Shares Outstanding, Basic 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Viridian Therapeutics, Inc.\DE quarterly Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2024.
  • Viridian Therapeutics, Inc.\DE Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 61.1M shares, a 44.6% increase year-over-year.
Weighted Average Number of Shares Outstanding, Basic, Trailing 12 Months (shares)
Weighted Average Number of Shares Outstanding, Basic, Quarterly Data (shares)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 61.1M +18.9M +44.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 44.8M +12.7M +39.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q4 2023 44.8M 44.8M +12.7M +39.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 43.7M +9.91M +29.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 43.3M +15.5M +55.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 42.2M +16.1M +61.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 32.1M +20.2M +169% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q4 2022 32.1M 32.1M +20.2M +169% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 33.7M +22.6M +202% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 27.8M +19.7M +242% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 26.1M +19.8M +312% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 11.9M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q4 2021 11.9M 11.9M +8.36M +235% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 11.2M +7.46M +201% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 8.11M +4.57M +129% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 6.34M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 3.56M 3.56M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 3.72M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 3.54M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.